![Chris Nave](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Nave
Director/Board Member at
EBR SYSTEMS, INC.
Net worth: - $ as of 2026-05-30
Profile
Chris Nave is currently Chief Executive Officer at Medical Research Commercialisation Fund Trust.
Current roles also include Chairman at PolyActiva Pty Ltd. and OccuRx Pty Ltd, Director & Member at Australian Investment Council Ltd., Founding Partner & Managing Director at Brandon Capital Partners Pty Ltd., Non-Executive Director at Osprey Medical, Inc. and EBR Systems, Inc., and Director at Global Kinetics Pty Ltd., BACE Therapeutics Pty Ltd., QUE Oncology, Inc., Azura Ophthalmics Ltd., Cardiora Pty Ltd., Certa Therapeutics Pty Ltd., and Pathios Therapeutics Ltd. Memberships include BioMelbourne Network and AusBiotech Ltd. Former positions include Director-Commercialization at Alfred Health, Director at Hatchtech Pty Ltd., Spinifex Pharmaceuticals Pty Ltd., Fibrotech Therapeutics Pty Ltd., and Athena Medicines Pty Ltd., Commercialization Director at Baker Heart & Diabetes Institute, Non-Executive Director at Otifex Therapeutics Pty Ltd., and Manager at Melbourne Ventures Pty Ltd. Education includes undergraduate and doctorate degrees from the University of Melbourne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EBR SYSTEMS, INC. -.--% | 2026-05-06 | 0 ( -.--% ) | - $ | 2026-05-30 |
Chris Nave active positions
| Companies | Position | Start |
|---|---|---|
| OSPY MEDI CDI | Director/Board Member | 2005-10-23 |
| EBR SYSTEMS, INC. | Director/Board Member | 2017-09-30 |
OccuRx Pty Ltd
 OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Chairman | - |
Certa Therapeutics Pty Ltd.
 Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company, which develops drugs for treatment for fibrotic diseases | Director/Board Member | - |
Australian Investment Council Ltd.
 Australian Investment Council Ltd. Miscellaneous Commercial ServicesCommercial Services Represents the private equity and venture capital industry | Director/Board Member | - |
Medical Research Commercialisation Fund Trust
 Medical Research Commercialisation Fund Trust Investment ManagersFinance Acts as Venture Capital Fund | Chief Executive Officer | - |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Director/Board Member | - |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Director/Board Member | - |
Cardiora Pty Ltd.
 Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund | Director/Board Member | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Former positions of Chris Nave
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Chris Nave
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
25
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 25 |
|---|---|
EBR Systems, Inc.
 EBR Systems, Inc. Medical SpecialtiesHealth Technology Develops implantable systems for wireless tissue stimulation | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Investment Council Ltd.
Australian Investment Council Ltd. Miscellaneous Commercial ServicesCommercial Services Represents the private equity and venture capital industry | Commercial Services |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Osprey Medical, Inc.
 Osprey Medical, Inc. Medical SpecialtiesHealth Technology Develops medicine for cardiovascular diseases | Health Technology |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical product company | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Melbourne Ventures Pty Ltd.
 Melbourne Ventures Pty Ltd. Investment ManagersFinance Offers commercial advisory and technology commercialization services | Finance |
Medical Research Commercialisation Fund Trust
Medical Research Commercialisation Fund Trust Investment ManagersFinance Acts as Venture Capital Fund | Finance |
BioMelbourne Network | |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Alfred Health
 Alfred Health Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Fibrotech Therapeutics Pty Ltd.
 Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops novel drugs candidates for the treatment of the fibrosis prevalent | Health Technology |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Develops treatment for ear diseases | Health Technology |
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology Operates as a clinical-stage ophthalmology company that develops drug-polymer conjugate technology | Health Technology |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for neurology and provides related services | Health Technology |
BACE Therapeutics Pty Ltd. | |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Health Technology |
OccuRx Pty Ltd
OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Azura Ophthalmics Pty Ltd.
 Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Designs ophthalmic keratolytics | Health Technology |
Cardiora Pty Ltd.
Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund | Miscellaneous |
Baker Heart & Diabetes Institute
 Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Owns and operates medical research institutes | Commercial Services |
Athena Medicines Pty Ltd. | |
Certa Therapeutics Pty Ltd.
Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company, which develops drugs for treatment for fibrotic diseases | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
- Stock Market
- Insiders
- Chris Nave
